Supplements

Tesamorelin HA 5mg

• 37/100 science score
• $70.39 price
• Promoted by Ben Greenfield

Overview

Tesamorelin scores moderately on effectiveness due to robust RCTs demonstrating 10-18% VAT reduction at 2mg/day in HIV patients (e.g., Falutz et al., Lancet 2010: n=404, P<0.0001; Stanley et al., 2024: n=38, P=0.001), via GH/IGF-1 stimulation. However, evidence is specific to HIV lipodystrophy; off-label general use lacks trials. Safety is low: FDA label warns of IGF-1-driven cancer risk, 5x diabetes hazard, 17% injection reactions, contraindications limit broad use. As a 5mg research vial, qual

Key strengths

• Strong RCT evidence for visceral fat reduction in indicated population
• Increases GH/IGF-1 for potential metabolic benefits
• Affordable research vials vs prescription cost

Our analysis

Avoid this product as a general supplement due to high risks and lack of regulation. Only consider under medical supervision for FDA-indicated HIV lipodystrophy. Research peptides pose purity and legality issues.

Frequently asked questions

Is Tesamorelin HA 5mg worth buying?

Tesamorelin HA 5mg has a Verify Influencers trust score of 37/100 based on ingredient quality, clinical evidence, and third-party testing.

What is the trust score for Tesamorelin HA 5mg?

Tesamorelin HA 5mg scored 37 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored